Core Scientific, Inc.
CORZQ
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -433.50% | -156.39% | 5.49% | 97.89% | 88.52% |
| Total Depreciation and Amortization | 24.55% | -9.45% | -33.37% | -48.13% | -57.34% |
| Total Amortization of Deferred Charges | 399.47% | 223.36% | -41.62% | -76.88% | -89.46% |
| Total Other Non-Cash Items | 2,560.50% | 3,458.47% | 47.25% | -116.98% | -97.11% |
| Change in Net Operating Assets | -116.55% | -66.66% | -55.09% | -63.44% | -65.11% |
| Cash from Operations | -34.12% | -68.13% | -50.42% | -70.56% | -68.27% |
| Capital Expenditure | -487.59% | 46.22% | 66.43% | 86.08% | 97.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 72.27% | -100.00% | 40.34% | -105.49% | -107.66% |
| Cash from Investing | -3,077.30% | 55.79% | 75.84% | 89.77% | 99.49% |
| Total Debt Issued | -- | 891.01% | -- | -- | -- |
| Total Debt Repaid | -596.22% | -634.81% | 18.82% | 48.81% | 68.91% |
| Issuance of Common Stock | -- | 127.24% | 121.07% | 119.61% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 190.70% | 531.77% | -- | -- |
| Cash from Financing | 1,935.58% | 1,630.71% | 130.54% | -80.00% | -114.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4,292.19% | 621.92% | 131.93% | 209.34% | 121.99% |
